Your session is about to expire
← Back to Search
Proton Therapy for Head and Neck Cancer
Study Summary
This trial is testing whether proton therapy can shrink tumors in patients with head and neck cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not had any other cancer within the last 2 years.I do not have any serious illnesses or social situations that would stop me from following the study's requirements.I have had a heart attack in the last 6 months or have heart failure needing constant treatment.My cancer is in my head or neck area, including the mouth and throat.My scans show no signs of cancer spread beyond its original site.I am not on any experimental drugs for my cancer.My cancer in the head or neck is not related to HPV.I am not currently receiving treatment for any other cancer.My larynx cancer is at an advanced stage or has spread to my lymph nodes.I have skin cancer (not melanoma), cervical carcinoma-in-situ, or low-grade prostate cancer.I am HIV positive and currently on antiretroviral therapy.I have had radiation in the same area where I would get head/neck radiation.I cannot have proton therapy due to metal in my body or other reasons.I have tested negative for COVID-19 or have been symptom-free for 14 days after a positive test. My vaccination status is documented.My diagnosis is one of the following: HPV-related cancer, germ cell tumor, blood cancer, neuroendocrine tumor, adenoid cystic carcinoma, bone sarcoma, or a benign tumor.I was fully active or had some restrictions before starting treatment.I am 18 years old or older.
- Group 1: Arm A (IMPT, cisplatin)
- Group 2: Arm B (IMPT, cisplatin)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are we currently enrolling people for this research project?
"Yes, this information can be found on clinicaltrials.gov. The trial was first advertised on February 21st 2021 and the most recent update was April 6th 2022."
Are there other examples in the medical literature of Cisplatin being used in treatment?
"City of Hope Comprehensive Cancer Center first studied cisplatin in 1997 and, as of now, 1198 trials have been completed while 773 are ongoing. A considerable number of these active studies are based in Rochester, Minnesota."
What is the primary purpose that Cisplatin is prescribed?
"Cisplatin is used to treat neoplasm metastasis and other conditions like advanced ovarian cancer. It may be employed when standard therapies have failed or in advance directives."
What is the projected sample size for this experiment?
"Yes, this study is open for recruitment and the clinicaltrials.gov website has the most recent information. The trial was first posted on February 21st, 2021 and was edited April 6th, 2022. There are plans to enroll 117 patients at 2 sites."
Does the FDA sanction use of Cisplatin?
"Cisplatin received a score of 2 from our team because while there is some data suggesting it is safe, none of the available information points to this medication being effective."
Share this study with friends
Copy Link
Messenger